|
|
November 16, 2009 Strategies for Merging and Analyzing Chemical and Biological Data for Effective Compound Prioritization Decisions |
Keynote Speaker for this event:
Brian Masek, Ph.D., Product Manager and Lead Scientist, Tripos International  |
|

Effective management of results from biological testing, chemical structure information and other disparate sources of discovery data is critical to decision-making in drug and molecular discovery projects, yet scientists often spend anywhere from minutes to hours each week dealing with mountains of data created from different programs, supplied in a variety of formats. Viewing information obtained from multiple sources contained in independent reports, and manually merging these disparate data sources together to determine which are the most promising compounds for further studies or tox analysis poses a regular time drain as well as a challenge to effective decision making. The ability to quickly and robustly determine which of many candidate compounds has the desired physicochemical properties and passes multiple design criteria is necessary to determine which compounds have the best chances of successfully navigating the drug discovery and development process.
Learn how to organize, analyze, and visualize chemical and biological data quickly and efficiently, enhancing efficiency and productivity. During this webinar, you will:
|
| THIS PROGRAM IS INTENDED FOR: |
|
-
Directors of Chemistry and Medicinal Chemistry
-
Medicinal Chemists
-
CADD Scientists
-
Discovery Researchers
-
Research Informatics Scientists and Managers
 |
|

|
Brian Masek, Ph.D., Product Manager and Lead Scientist, Tripos International
Brian Masek is a product manager and Lead Scientist at Tripos, where his research involves the development and validation of novel computer-assisted drug discovery methods with a current focus on molecular invention to generate drug candidates that optimize multiple drug design criteria and informatics tools for multicriteria drug prioritization. Before joining Tripos, Brian was the Director for Scientific Research and Development at Optive Research, Inc. where he continued the scientific research and commercial software development that Prof. Robert S. Pearlman and the Laboratory for the Development of Computer Assisted Drug Discovery Software had conducted. From 1986 until 2001, Brian held a variety of positions in the Research Department at AstraZeneca Pharmaceuticals where his research focused on developing novel CADD methods and using these CADD methods to discover new drugs. Brian received a BA in Chemistry from Kearney State College and a PhD in Physical Organic Chemistry from the California Institute of Technology. |
| ABOUT OUR SPONSORING PARTNER: |
|
|
|
Tripos, a Certaraä Company, is a global leader in innovative scientific solutions enabling life science researchers to improve the efficiency of molecular discovery. Established in 1979, Tripos was the first company to bring scientific computational drug discovery capabilities to the pharmaceutical, chemical and food design industries, and today helps a broad range of companies and research facilities accelerate the identification and optimization of new compounds that have the potential to become marketed drugs, foods, flavorings and fragrances. Headquartered in St. Louis, Missouri, Tripos serves more than 1,000 customers spanning over 46 countries.
|
| ABOUT OUR MEDIA PARTNERS: |
|

"http://www.pharmcast.com/ is the world leading website designed specifically for pharmaceutical, clinical and biotechnology professionals. http://www.pharmcast.com/ brings up-to-date information on pharmaceutical patents, FDA, news, jobs and Buyer's Guide to our visitors. It was created and is maintained by pharmaceutical and biotechnology professionals. Visit http://www.pharmcast.com/ and discover for yourself why it is so popular among professionals."

|
|
European Pharmaceutical Manufacturer (EPM) magazine, published by Rapid News Communications Group, is the pharmaceutical supply chain for ingredients, equipment, contract services and more. Now in its ninth year of publication, it is the only tabloid-style publication in the field of pharmaceutical manufacture in Europe. For fresh, up-to-date news, visit the EPM website, http://www.pharm-europe.com/. |
| |